Table 1 Baseline clinical and demographic characteristics
Characteristic | Â |
|---|---|
Median age (range)—year | 66 (17–92) |
Female gender—no. (%) | 25 (27.8%) |
Ethnicity—no. (%) | |
 Caucasian | 59 (65%) |
 African American | 8 (9%) |
 Hispanic | 5 (6%) |
 Asian/Pacific Islander | 3 (3%) |
 Other/unknown | 15 (17%) |
Smoking history—no. (%) | |
 No | 46 (51%) |
BMI status—no. (%) | |
 Underweight | 2 (2%) |
 Normal | 29 (32%) |
 Overweight | 38 (42%) |
 Obese | 21 (23%) |
IMDC risk scorea—no. (%) | |
 Favorable | 18 (20%) |
 Intermediate | 59 (65%) |
 Poor | 6 (6%) |
No. of organs with metastasis—no. (%) | |
 1 | 8 (9%) |
 > 2 | 73 (81%) |
Most common sites of metastasis—no. (%) | |
 Lung | 66 (73%) |
 Spine | 31 (34%) |
 Liver | 23 (25%) |
 Brain | 7 (8%) |
Nephrectomy—no. (%) | 74 (82%) |
Previous radiotherapy—no. (%) | 52 (58%) |
ICI line of treatment—no. (%) | |
 First line | 8 (9%) |
 Second line | 43 (48%) |
 Third line | 28 (31%) |
 Fourth or more | 11 (12%) |